PubMed2 min read
Artificial intelligence in pediatric allergic diseases: what the clinician needs to know
CONCLUSION: AI is closer to the bedside in pediatric allergy than in many other areas of pediatrics, but few tools are ready for autonomous clinical use. No trial has yet shown that acting on an AI-derived risk estimate improves clinical outcomes in children.
By Antonio Andrea SenatorePubMed - AI Research
Read the full story
Originally published by PubMed - AI Research on Nov 4, 2026.
Comments
Sign in to join the discussion.